These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31361430)

  • 1. Opioid misuse, labor market outcomes, and means-tested public expenditures: a conceptual framework.
    Segel JE; Shi Y; Moran JR; Scanlon DP
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S270-S276. PubMed ID: 31361430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revenue Losses to State and Federal Government From Opioid-related Employment Reductions.
    Segel JE; Shi Y; Moran JR; Scanlon DP
    Med Care; 2019 Jul; 57(7):494-497. PubMed ID: 30844906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of the opioid epidemic, in context.
    Kawasaki S; Sharfstein JM
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S241-S242. PubMed ID: 31361433
    [No Abstract]   [Full Text] [Related]  

  • 4. Simulated impact of medicaid expansion on the economic burden of opioid use disorder in North Carolina.
    Barbosa C; Dowd WN; Buell N; Allaire B; Bobashev G
    Int J Drug Policy; 2024 Jun; 128():104449. PubMed ID: 38733650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of the opioid epidemic on states: the case of Medicaid.
    Leslie DL; Ba DM; Agbese E; Xing X; Liu G
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S243-S249. PubMed ID: 31361426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013.
    Florence CS; Zhou C; Luo F; Xu L
    Med Care; 2016 Oct; 54(10):901-6. PubMed ID: 27623005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated costs to the Pennsylvania criminal justice system resulting from the opioid crisis.
    Zajac G; Nur SA; Kreager DA; Sterner G
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S250-S255. PubMed ID: 31361427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing the next crisis: six critical questions about the opioid epidemic that need answers.
    Scanlon DP; Hollenbeak CS
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S234-S238. PubMed ID: 31361431
    [No Abstract]   [Full Text] [Related]  

  • 9. The opioid epidemic: the cost of services versus the cost of despair.
    Plough AL
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S232-S233. PubMed ID: 31361434
    [No Abstract]   [Full Text] [Related]  

  • 10. The personal and national costs of early retirement because of spinal disorders: impacts on income, taxes, and government support payments.
    Schofield DJ; Shrestha RN; Percival R; Passey ME; Callander EJ; Kelly SJ
    Spine J; 2012 Dec; 12(12):1111-8. PubMed ID: 23092718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor vehicle safety, health care, and taxes. National Highway Traffic Safety Administration, U.S. Department of Transportation.
    Prehosp Disaster Med; 1994; 9(1):11-23. PubMed ID: 10155483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework.
    Connolly MP; Baker CL; Kotsopoulos N
    J Med Econ; 2018 Jun; 21(6):571-576. PubMed ID: 29376747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considering the child welfare system burden from opioid misuse: research priorities for estimating public costs.
    Crowley DM; Connell CM; Jones D; Donovan MW
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S256-S263. PubMed ID: 31361428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond rescue, treatment, and prevention: understanding the broader impact of the opioid epidemic at the state level.
    Fassbender L; Zander GB; Levine RL
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S239-S240. PubMed ID: 31361432
    [No Abstract]   [Full Text] [Related]  

  • 15. Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United States.
    Kirson NY; Shei A; White AG; Birnbaum HG; Ben-Joseph R; Rossiter LF; Michna E
    Pain Med; 2014 Sep; 15(9):1450-4. PubMed ID: 25041231
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review.
    Oderda GM; Lake J; Rüdell K; Roland CL; Masters ET
    J Pain Palliat Care Pharmacother; 2015; 29(4):388-400. PubMed ID: 26654413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The opioid epidemic, neonatal abstinence syndrome, and estimated costs for special education services.
    Morgan PL; Wang Y
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S264-S269. PubMed ID: 31361429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal costs of prescription opioid abuse, dependence, and misuse in the United States.
    Birnbaum HG; White AG; Schiller M; Waldman T; Cleveland JM; Roland CL
    Pain Med; 2011 Apr; 12(4):657-67. PubMed ID: 21392250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review.
    Robinson LS; Sarkies M; Brown T; O'Brien L
    Injury; 2016 Dec; 47(12):2614-2626. PubMed ID: 27751502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.